Chengdu Kanghong Biotech Co.,Ltd.   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Chengdu China (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2009
NCT01242254
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Chengdu Kanghong Biotech Co., Ltd. | Chengdu Kanghong Biotech Co.,Ltd. | Chengdu Kanghong Biotechnology Co.,Ltd. | Chengdu Kanghong Pharmaceutical Co., Ltd. | Chengdu Kanghong Pharmaceutical Group Co., Ltd.